Cargando…
The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1
PURPOSE: Angiogenesis is an important mediator in tumor progression. Vascular endothelial growth factor (VEGF) is one of the major cytokines that can influence angiogenesis. However, the potential mechanism of tumor growth inhibition through anti-VEGF agents is still unclear. This study was performe...
Autores principales: | Li, Jiao, Cui, Yan, Wang, Qin, Guo, Dadong, Pan, Xuemei, Wang, Xingrong, Bi, Hongsheng, Chen, Wei, Liu, Zhengfeng, Zhao, Shengya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021672/ https://www.ncbi.nlm.nih.gov/pubmed/24868139 |
Ejemplares similares
-
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019) -
VEGF-VEGFR Signals in Health and Disease
por: Shibuya, Masabumi
Publicado: (2014) -
Assessment of mouse VEGF neutralization by ranibizumab and aflibercept
por: Ichiyama, Yusuke, et al.
Publicado: (2022) -
Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
por: Chang, Yi-Wen, et al.
Publicado: (2014) -
Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer
por: Dziobek, Konrad, et al.
Publicado: (2019)